Atabak Mokari - Net Worth and Insider Trading

Atabak Mokari Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Atabak Mokari owns 3 companies in total, including Bellicum Pharmaceuticals Inc (BLCM) , IRIDEX Corp (IRIX) , and Corcept Therapeutics Inc (CORT) .

Click here to see the complete history of Atabak Mokari’s form 4 insider trades.

Insider Ownership Summary of Atabak Mokari

Ticker	Comapny	Transaction Date	Type of Owner
BLCM	Bellicum Pharmaceuticals Inc	2018-12-19	Sr. VP and CFO
IRIX	IRIDEX Corp	2016-07-11	CFO and VP & Corp Development
CORT	Corcept Therapeutics Inc	2021-03-01	Chief Financial Officer

Atabak Mokari Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Atabak Mokari Ownership Network

Ownership Network List of Atabak Mokari

No Data

Ownership Network Relation of Atabak Mokari

Atabak Mokari Owned Company Details

What does Bellicum Pharmaceuticals Inc do?

Who are the key executives at Bellicum Pharmaceuticals Inc?

Atabak Mokari is the Sr. VP and CFO of Bellicum Pharmaceuticals Inc. Other key executives at Bellicum Pharmaceuticals Inc include Chief Development Officer Charity Scripture , Principal Accounting Officer Charles S. Grass , and director & President and CEO Richard A. Fair .

Bellicum Pharmaceuticals Inc (BLCM) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Bellicum Pharmaceuticals Inc (BLCM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Bellicum Pharmaceuticals Inc (BLCM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Bellicum Pharmaceuticals Inc (BLCM)'s detailed insider trading history can be found in Insider Trading Tracker table.

Bellicum Pharmaceuticals Inc Insider Transactions

No Available Data

What does IRIDEX Corp do?

Who are the key executives at IRIDEX Corp?

Atabak Mokari is the CFO and VP & Corp Development of IRIDEX Corp. Other key executives at IRIDEX Corp include 10 percent owner Topcon Corp , 10 percent owner Topcon America Corp , and Interim CFO Fuad Ahmad .

IRIDEX Corp (IRIX) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of IRIDEX Corp (IRIX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of IRIDEX Corp (IRIX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

IRIDEX Corp (IRIX)'s detailed insider trading history can be found in Insider Trading Tracker table.

IRIDEX Corp Insider Transactions

No Available Data

What does Corcept Therapeutics Inc do?

Who are the key executives at Corcept Therapeutics Inc?

Atabak Mokari is the Chief Financial Officer of Corcept Therapeutics Inc. Other key executives at Corcept Therapeutics Inc include Chief Development Officer William Guyer , CHIEF FINANCIAL OFFICER Gary Charles Robb , and Chief Accounting Officer Joseph Douglas Lyon .

Corcept Therapeutics Inc (CORT) Insider Trades Summary

Over the past 18 months, Atabak Mokari made no insider transaction in Corcept Therapeutics Inc (CORT). Other recent insider transactions involving Corcept Therapeutics Inc (CORT) include a net sale of 70,000 shares made by Joseph Douglas Lyon , a net sale of 28,750 shares made by Swisher Daniel N Jr , and a net sale of 225,000 shares made by Sean Maduck .

In summary, during the past 3 months, insiders sold 44,101 shares of Corcept Therapeutics Inc (CORT) in total and bought 0 shares, with a net sale of 44,101 shares. During the past 18 months, 517,899 shares of Corcept Therapeutics Inc (CORT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 517,899 shares.

Corcept Therapeutics Inc (CORT)'s detailed insider trading history can be found in Insider Trading Tracker table.

Corcept Therapeutics Inc Insider Transactions

No Available Data

Atabak Mokari Mailing Address

Above is the net worth, insider trading, and ownership report for Atabak Mokari. You might contact Atabak Mokari via mailing address: 1212 Terra Bella Avenue, Mountain View Ca 94043.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.